UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50

Benzinga Newsdesk www.benzinga.com Positive 74.8%

Neg 0% Neu 0% Pos 74.8%

UBS analyst Josh Silverstein maintains Helmerich & Payne (NYSE:HP) with a Buy and raises the price target from $49 to $50.